Lifeway Foods Acknowledges ISS Recommendation to Reject Dissident Campaign
Get Alerts LWAY Hot Sheet
Join SI Premium – FREE
In its report, ISS concluded that "the dissident has not presented a compelling case for change" and advised shareholders to "DO NOT VOTE" on all proposals put forth by Ludmila and
"We appreciate ISS's thorough review and are pleased that their recommendation supports our belief that this consent solicitation is unwarranted, disruptive and not in the best interest of Lifeway shareholders," said
The ISS analysis noted that:
- Lifeway's "financial performance has been directionally positive" and its "share price [has] rallied over the preceding year on multiple positive earnings announcements," with total shareholder return significantly outperforming peers in the Russell 3000 Food Producers Index.
- The dissident group's critiques "are generally presented without adequate context," and the dissident group "does not clearly establish how various developments have actually impacted shareholder returns."
- The dissident group "has not presented a plan should it successfully secure a majority of board seats" for governance or operational improvement.
- The dissident nominees include individuals who previously contributed to governance concerns during their past tenures at the Company.
- "The Lifeway Board and management team remain focused on maximizing shareholder value and will continue to pursue all opportunities to drive additional value," added Smolyansky. "We encourage shareholders to follow ISS's guidance and take no action on the consent solicitation."
About Lifeway Foods, Inc.
Lifeway Foods, Inc., which has been recognized as one of Forbes' Best Small Companies, is America's leading supplier of the probiotic, fermented beverage known as Kefir. In addition to its line of drinkable Kefir, the company also produces a variety of cheeses and a ProBugs line for kids. Lifeway's tart and tangy fermented dairy products are now sold across
Important Additional Information
The Company intends to file a proxy statement on Schedule 14A, an accompanying BLUE proxy card and other relevant documents with the U.S. Securities and Exchange Commission (the "SEC") in connection with the solicitation of proxies from the Company's shareholders for the Company's 2025 annual meeting of shareholders. THE COMPANY'S SHAREHOLDERS ARE STRONGLY ENCOURAGED TO READ THE COMPANY'S DEFINITIVE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO), THE ACCOMPANYING BLUE PROXY CARD AND ALL OTHER DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Investors and shareholders may obtain a copy of the definitive proxy statement, an accompanying BLUE proxy card, any amendments or supplements to the definitive proxy statement and other documents filed by the Company with the SEC at no charge at the SEC's website at www.sec.gov. Copies will also be available at no charge by visiting the "Investor Relations" tab of the Company's website at http://lifewaykefir.com/investor-relations/. The Company may file a consent revocation statement, in which case all references to a proxy statement, proxies, proxy cards and solicitation of proxies referenced in this "Important Additional Information" section and the "Participants in the Solicitation" section below shall be deemed to refer to such consent revocation statement, consent revocations, revocation cards and solicitation of consent revocations.
Participants in the Solicitation
The Company, each of its independent directors (
Contact:
Perceptual Advisors
Email: [email protected]
Derek Miller
Vice President of Communications, Lifeway Foods
Email: [email protected]
General inquiries:
Lifeway Foods, Inc.
Phone: 847-967-1010
Email: [email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/lifeway-foods-acknowledges-iss-recommendation-to-reject-dissident-campaign-302516634.html
SOURCE Lifeway Foods, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alzamend Neuro fMRI data accepted for neuroscience conference poster
- Vox Royalty agrees to buy two Australian royalties for A$3.4M
- XTEND's X-Strike lethality package accepted into Pentagon drone program
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share